|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 63/00 | |
| C07J 71/00 | |||
| A61P 29/00 | |||
| A61K 31/58 | |||
| A61K 31/585 | |||
| A61K 31/56 |
| (11) | Patento numeris | 3353190 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16781915.0 |
| Europos patento paraiškos padavimo data | 2016-09-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/053545 |
| Data | 2016-09-23 |
| (87) | Numeris | WO 2017/053868 |
| Data | 2017-03-30 |
| (30) | Numeris | Data | Šalis |
| 201562222632 P | 2015-09-23 | US |
| (72) |
VISNICK, Melean, US
JIANG, Xin, US
HOTEMA, Martha, R., US
LEE, Chitase, US
CAPRATHE, Bradley, William, US
ROARK, William, H., US
BOLTON, Gary, US
|
| (73) |
Reata Pharmaceuticals, Inc.,
2801 Gateway Drive, Suite 150, Irving, TX 75063-2648,
US
|
| (54) | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES |
| C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES |